{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:11:16Z","timestamp":1791159076741,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Human Genome Research Institute and National Institutes of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ymgme.2012.04.024","type":"journal-article","created":{"date-parts":[[2012,5,6]],"date-time":"2012-05-06T12:35:24Z","timestamp":1336307724000},"page":"257-263","source":"Crossref","is-referenced-by-count":126,"title":["The role of saposin C in Gaucher disease"],"prefix":"10.1016","volume":"106","author":[{"given":"Rafael J.","family":"Tamargo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Velayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.04.024_bb0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-2776(10)05002-9","article-title":"The immunological functions of saposins","volume":"105","author":"Darmoise","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0010","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)40540-1","article-title":"Saposins: structure, function, distribution, and molecular genetics","volume":"33","author":"Kishimoto","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0015","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1022530508763","article-title":"Saposins and their interaction with lipids","volume":"24","author":"Vaccaro","year":"1999","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0020","series-title":"Gaucher disease","author":"Futerman","year":"2006"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1997.9958","article-title":"Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside","volume":"341","author":"Hiraiwa","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0030","doi-asserted-by":"crossref","first-page":"9953","DOI":"10.1074\/jbc.270.17.9953","article-title":"Structural analysis of saposin C and B. Complete localization of disulfide bridges","volume":"270","author":"Vaccaro","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kucha\u0159","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2004.10.004","article-title":"A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans","volume":"84","author":"Spiegel","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0045","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00219682","volume":"92","author":"Bradova","year":"1993","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation","volume":"10","author":"Hulkov\u00e1","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejpn.2007.05.004","article-title":"Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency","volume":"12","author":"Deconinck","year":"2008","journal-title":"Eur. J. Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0065","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1073\/pnas.87.7.2541","article-title":"Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect","volume":"87","author":"Kretz","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/BF02072213","article-title":"Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study","volume":"150","author":"Schlote","year":"1991","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0075","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/hmg\/ddp531","article-title":"Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \"simple\" disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0085","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher Disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0090","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0167-4838(90)90122-V","article-title":"Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease","volume":"1041","author":"Aerts","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15227950500405296","article-title":"Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum","volume":"24","author":"Eblan","year":"2005","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0065-3101(24)00037-9","article-title":"Hydrops fetalis: lysosomal storage disorders in extremis","volume":"46","author":"Stone","year":"1999","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0115","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1073\/pnas.68.11.2810","article-title":"Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro","volume":"68","author":"Ho","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0120","doi-asserted-by":"crossref","first-page":"15339","DOI":"10.1016\/S0021-9258(18)66873-5","article-title":"Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts","volume":"261","author":"Fujibayashi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/0005-2760(86)90077-9","article-title":"Biosynthesis of the sulfatide\/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts","volume":"875","author":"Fujibayashi","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.2842863","article-title":"Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus","volume":"241","author":"O'Brien","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/bchm3.1988.369.1.317","article-title":"The precursor of sulfatide activator protein is processed to three different proteins","volume":"369","author":"Furst","year":"1988","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0140","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0006-291X(88)80855-6","article-title":"Saposin D: a sphingomyelinase activator","volume":"156","author":"Morimoto","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0145","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1073\/pnas.86.9.3389","article-title":"Saposin A: second cerebrosidase activator protein","volume":"86","author":"Morimoto","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0150","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0003-9861(84)90479-X","article-title":"Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1)","volume":"233","author":"Inui","year":"1984","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1096\/fasebj.5.3.2001789","article-title":"Saposin proteins: structure, function, and role in human lysosomal storage disorders","volume":"5","author":"O'Brien","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(92)90210-M","article-title":"Activator proteins and topology of lysosomal sphingolipid catabolism","volume":"1126","author":"Furst","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/oxfordjournals.jbchem.a122629","article-title":"Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator","volume":"105","author":"Nakano","year":"1989","journal-title":"J. Biochem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molbrainres.2004.06.027","article-title":"Conservation of expression and alternative splicing in the prosaposin gene","volume":"129","author":"Cohen","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mrd.1080400112","article-title":"Role of sulfated glycoprotein-1 (SGP-1) in the disposal of residual bodies by Sertoli cells of the rat","volume":"40","author":"Igdoura","year":"1995","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0180","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1093\/emboj\/cdg629","article-title":"The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin","volume":"22","author":"Lefrancois","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s004410050549","article-title":"Trafficking of sulfated glycoprotein-1 (prosaposin) to lysosomes or to the extracellular space in rat Sertoli cells","volume":"283","author":"Igdoura","year":"1996","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0190","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.yexcr.2011.07.017","article-title":"Prosaposin sorting is mediated by oligomerization","volume":"317","author":"Yuan","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0195","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/0006-291X(89)92728-9","article-title":"Sphingolipid hydrolase activator proteins and their precursors","volume":"165","author":"Sano","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0200","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0006-291X(05)80236-0","article-title":"Secretion of sphingolipid hydrolase activator precursor, prosaposin","volume":"176","author":"Hineno","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0006-291X(05)81415-9","article-title":"Isolation and characterization of prosaposin from human milk","volume":"181","author":"Kondoh","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/014850100262146","article-title":"Role of prosaposin in the male reproductive system: effect of prosaposin inactivation on the testis, epididymis, prostate, and seminal vesicles","volume":"44","author":"Morales","year":"2000","journal-title":"Arch. Androl."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0215","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1073\/pnas.91.20.9593","article-title":"Identification of prosaposin as a neurotrophic factor","volume":"91","author":"O'Brien","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0220","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1046\/j.1471-4159.1996.66052197.x","article-title":"A hydrophilic peptide comprising 18 amino acid residues of the prosaposin sequence has neurotrophic activity in vitro and in vivo","volume":"66","author":"Kotani","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neures.2011.06.001","article-title":"Chronological changes in prosaposin in the developing rat brain","volume":"71","author":"Xue","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0230","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1515\/bchm3.1987.368.2.1571","article-title":"Complete amino-acid sequence and carbohydrate content of the naturally occurring glucosylceramide activator protein (A1 activator) absent from a new human Gaucher disease variant","volume":"368","author":"Kleinschmidt","year":"1987","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0235","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.str.2008.02.016","article-title":"Crystal structures of human saposins C and D: implications for lipid recognition and membrane interactions","volume":"16","author":"Rossmann","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0240","doi-asserted-by":"crossref","first-page":"30576","DOI":"10.1074\/jbc.270.51.30576","article-title":"pH-dependent conformational properties of saposins and their interactions with phospholipid membranes","volume":"270","author":"Vaccaro","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0245","doi-asserted-by":"crossref","first-page":"14729","DOI":"10.1021\/bi0301338","article-title":"Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles","volume":"42","author":"de Alba","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0250","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/pro.5560040415","article-title":"Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase","volume":"4","author":"Weiler","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0255","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/prot.21554","article-title":"An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions - relevance for Gaucher disease","volume":"70","author":"Atrian","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0005-2744(75)90199-0","article-title":"Glucocerebrosidase: stoichiometry of association between effector and catalytic proteins","volume":"397","author":"Ho","year":"1975","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1432-1033.1987.tb10907.x","article-title":"Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts","volume":"163","author":"Aerts","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0270","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0003-9861(85)90609-5","article-title":"Further studies on the activation of glucocerebrosidase by a heat-stable factor from Gaucher spleen","volume":"236","author":"Prence","year":"1985","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0275","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1021\/bi051944+","article-title":"Characterization of human saposins by NMR spectroscopy","volume":"45","author":"John","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0167-4838(86)90010-5","article-title":"In situ radiation-inactivation size of fibroblast membrane-bound acid beta-glucosidase in Gaucher type 1, type 2 and type 3 disease","volume":"870","author":"Choy","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0285","doi-asserted-by":"crossref","first-page":"973231","DOI":"10.4061\/2011\/973231","article-title":"A Guided Tour of the Structural Biology of Gaucher Disease: Acid-beta-Glucosidase and Saposin C","volume":"2011","author":"Lieberman","year":"2011","journal-title":"Enzyme Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0290","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jmb.2006.08.009","article-title":"Direct visualization of saposin remodelling of lipid bilayers","volume":"362","author":"Alattia","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0295","doi-asserted-by":"crossref","first-page":"17394","DOI":"10.1073\/pnas.0704998104","article-title":"Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C","volume":"104","author":"Alattia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0300","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chemphyslip.2004.09.002","article-title":"Direct AFM observation of saposin C-induced membrane domains in lipid bilayers: from simple to complex lipid mixtures","volume":"132","author":"You","year":"2004","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0305","doi-asserted-by":"crossref","first-page":"30271","DOI":"10.1074\/jbc.273.46.30271","article-title":"Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators","volume":"273","author":"Wilkening","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-5793(94)00659-8","article-title":"Saposin C induces pH-dependent destabilization and fusion of phosphatidylserine-containing vesicles","volume":"349","author":"Vaccaro","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0315","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1073\/pnas.1200764109","article-title":"Saposins utilize two strategies for lipid transfer and CD1 antigen presentation","volume":"109","author":"Leon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1073\/pnas.0136947100","article-title":"Crystal structure of saposin B reveals a dimeric shell for lipid binding","volume":"100","author":"Ahn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0325","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Sun","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0330","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0335","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0340","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0345","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1111\/j.1742-4658.2007.06042.x","article-title":"Pharmacologic chaperoning as a strategy to treat Gaucher disease","volume":"274","author":"Yu","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0350","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1074\/jbc.M511110200","article-title":"Analyses of variant acid beta-glucosidases: effects of Gaucher disease mutations","volume":"281","author":"Liou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20050325","article-title":"The N370S (Asn370\u2013>Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C","volume":"390","author":"Salvioli","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0360","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1074\/jbc.M110.150433","article-title":"X-ray and biochemical analysis of N370S mutant human acid beta-glucosidase","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0365","doi-asserted-by":"crossref","first-page":"42105","DOI":"10.1074\/jbc.M110.172098","article-title":"Molecular basis of reduced glucosylceramidase activity in the most common Gaucher disease mutant, N370S","volume":"285","author":"Offman","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0370","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI116276","article-title":"Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease","volume":"91","author":"van Weely","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0375","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0380","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1111\/j.1742-4658.2006.05410.x","article-title":"Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients","volume":"273","author":"Chang","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0485","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0390","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Tylki-Szymanska","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0395","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ymgme.2011.09.010","article-title":"Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form - No positive effects after 2-years of miglustat therapy","volume":"104","author":"Tylki-Szymanska","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0400","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/BF01716064","article-title":"Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder","volume":"67","author":"Christomanou","year":"1989","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0410","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0415","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00439-005-1288-x","article-title":"A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity","volume":"117","author":"Diaz-Font","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/S0022-3476(03)00302-0","article-title":"Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3","volume":"143","author":"Goker-Alpan","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0425","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0430","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0435","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G","article-title":"Prosaposin: a myelinotrophic protein that promotes expression of myelin constituents and is secreted after nerve injury","volume":"26","author":"Hiraiwa","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.ymgme.2012.04.024_bb0445","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0450","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng0894-451","article-title":"Phenotypic diversity, allelic series and modifier genes","volume":"7","author":"Romeo","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0455","first-page":"79","article-title":"Complex alleles of the acid beta-glucosidase gene in Gaucher disease","volume":"47","author":"Latham","year":"1990","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0460","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1193-274","article-title":"A mutation in CFTR produces different phenotypes depending on chromosomal background","volume":"5","author":"Kiesewetter","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0465","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and \"modifier\" polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0470","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.7.10.1020","article-title":"Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease","volume":"7","author":"Winfield","year":"1997","journal-title":"Genome Res."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0475","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/humu.21566","article-title":"A mutation in SCARB2 is a modifier in gaucher disease","volume":"32","author":"Velayati","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.04.024_bb0480","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1073\/pnas.87.9.3493","article-title":"Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases","volume":"87","author":"Morimoto","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T07:05:54Z","timestamp":1713942354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1096719212001679"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.04.024","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}